ascopubs.org

Systematic Review of Pretreatment Prostate-Specific Antigen Velocity and Doubling Time As Predictors for Prostate Cancer

We conducted a systematic review of studies published before March 2007 in which a PSA dynamic (velocity or doubling time) was calculated in patients before definitive treatment, a subsequent event ...
San Antonio Express-News

PSA velocity testing a poor predictor of prostate cancer

Cancer organizations commonly recommend prostate biopsies for men who have experienced a rapid rise in PSA levels. But according to findings from a San Antonio study published Feb. 24 in the Journal ...
ascopubs.org

Pretreatment Prostate-Specific Antigen (PSA) Velocity and Doubling Time Are Associated With Outcome but Neither Improves Prediction of Outcome Beyond Pretreatment PSA Alone in ...

Controversy exists as to whether current pretreatment prostate-specific antigen (PSA) dynamics enhance outcome prediction in patients undergoing treatment for prostate cancer. We assessed whether ...
Nature

A big data-based prediction model for prostate cancer incidence in Japanese men

To define a normal range for PSA values (ng/mL) by age and create a prediction model for prostate cancer incidence. We conducted a retrospective analysis using 263,073 observations of PSA values in ...
EurekAlert!

PSA velocity's clinical usefulness remains unclear

Some studies have suggested that the rate of change of prostate-specific antigen (PSA) levels may correspond with prostate cancer survival. But this does not necessarily mean that PSA velocity will be ...
EurekAlert!

High pretreatment PSA velocity predicts worse outcome

The most significant single predictor of aggressive prostate cancer is an elevated rate of increase in prostate specific antigen (PSA) levels, according to a new study. Published in the July 1, 2007 ...
Business Insider

20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina

Patented Algorithm Designed to Help Identify Otherwise Dangerous Prostate Tumors Earlier Using Repeat Blood Test Results Licensing Agreement Expands 20/20 BioLabs’ AI-Enabled Multi-Cancer Early ...
Medical Xpress

Myths about PSA tests and prostate cancer screening

The understanding of prostate cancer has significantly evolved in the past 15 years. However, many people—including primary care providers—may not be aware of the current guidelines for prostate ...
Medical Xpress

High-intensity interval training beneficial in prostate cancer

(HealthDay)—For men with low-risk to favorable intermediate-risk prostate cancer undergoing active surveillance, high-intensity interval training (HIIT) increases peak oxygen consumption and is ...
manilatimes

20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina

Licensing Agreement Expands 20/20 BioLabs’ AI-Enabled Multi-Cancer Early Detection Platform GAITHERSBURG, Md., May 12, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. ("20/20”) (Nasdaq: AIDX), an early ...
Nasdaq

20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina

GAITHERSBURG, Md., May 12, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (“20/20”) (Nasdaq: AIDX), an early market entrant in cutting-edge, AI powered laboratory-based blood tests for the early ...